Cerulean Pharma Inc Stock Nasdaq
Equities
US15708Q1058
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 5.43M | Sales 2025 * | 33.37M | Capitalization | 30.77M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -7M | EV / Sales 2024 * | 5.67 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-1.13
x | P/E ratio 2025 * |
-5.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Cerulean Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 75 | 13-12-31 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+48.54% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |